International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
暂无分享,去创建一个
Jilly F. Evans | J. Drazen | S. Dahlén | Takao Shimizu | C. Serhan | T. Yokomizo | C. Brink | S. Nicosia | D. Hay
[1] J. Shelhamer,et al. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: Involvement of the lipoxygenase pathway , 1990, Agents and Actions.
[2] I. Ahnfelt-Rønne,et al. LTD4 increases cytosolic free calcium and inositol phosphates in human neutrophils: inhibition by the novel LTD4 receptor antagonist, SR2640, and possible relation to modulation of chemotaxis , 1990, Agents and Actions.
[3] V. Fiedler,et al. Comparison of cardiac and hemodynamic effects of plateletactivating factor-acether and leukotriene D4 in anesthetized dogs , 1987, Basic Research in Cardiology.
[4] D. Thompson,et al. Involvement of capsaicin-sensitive afferent neurones in a vagal-dependent interaction between leukotriene D4 and histamine on bronchomotor tone , 1984, Agents and Actions.
[5] C. Román,et al. Contraction of guinea pig inferior vena cava by eicosanoids , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] S. Dahlén,et al. Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] B. Uvnäs. Slow Reacting Substance , 1965, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[8] A. M. Vikhert,et al. Effect of lipoxin B on colony-forming ability of human peripheral blood mononuclears in a diffusion chamber , 2004, Bulletin of Experimental Biology and Medicine.
[9] 英明 小笠原. Characterization of mouse cysteinyl leukotriene receptors , 2003 .
[10] S. Dahlén,et al. Pharmacological evidence for a novel cysteinyl‐leukotriene receptor subtype in human pulmonary artery smooth muscle , 2002, British journal of pharmacology.
[11] F. Martin,et al. Lipoxin, leukotriene, and PDGF receptors cross‐talk to regulate mesangial cell proliferation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] S. Marullo,et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor , 2002, Nature Medicine.
[13] J. Stankova,et al. Threonine 308 within a Putative Casein Kinase 2 Site of the Cytoplasmic Tail of Leukotriene B4 Receptor (BLT1) Is Crucial for Ligand-induced, G-protein-coupled Receptor-specific Kinase 6-mediated Desensitization* , 2002, The Journal of Biological Chemistry.
[14] Takao Shimizu,et al. Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2 , 2002, The Journal of Biological Chemistry.
[15] B. Hallberg,et al. Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. , 2002, Journal of cell science.
[16] G. Rovati,et al. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma. , 2002, Biochemical pharmacology.
[17] H. You,et al. Leukotriene B4 Stimulates Rac-ERK Cascade to Generate Reactive Oxygen Species That Mediates Chemotaxis* , 2002, The Journal of Biological Chemistry.
[18] M. Bäck,et al. Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. , 2002, European journal of pharmacology.
[19] Ji Ming Wang,et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Walch,et al. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. , 2002, Acta physiologica Scandinavica.
[21] N. Copeland,et al. The Murine Cysteinyl Leukotriene 2 (CysLT2) Receptor , 2001, Journal of Biological Chemistry.
[22] C. Serhan,et al. Aspirin‐triggered lipoxin A4 and lipoxin A4 up‐regulate transcriptional corepressor NAB1 in human neutrophils , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] R. Stocco,et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT1) receptors , 2001 .
[24] H. Mita,et al. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[25] A. Sampson,et al. A Tale of Two CysLTs , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] S. Cole,et al. Characterization of Binding of Leukotriene C4 by Human Multidrug Resistance Protein 1 , 2001, The Journal of Biological Chemistry.
[27] T. Saito,et al. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. , 2001, Biochemical and biophysical research communications.
[28] J. Stankova,et al. IL-13 and IL-4 Up-Regulate Cysteinyl Leukotriene 1 Receptor Expression in Human Monocytes and Macrophages1 , 2001, The Journal of Immunology.
[29] K. Austen,et al. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. Dahlgren,et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2* , 2001, The Journal of Biological Chemistry.
[31] A. Sjölander,et al. Leukotriene D(4) affects localisation of vinculin in intestinal epithelial cells via distinct tyrosine kinase and protein kinase C controlled events. , 2001, Journal of cell science.
[32] J. Palmblad,et al. Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor. , 2001, European journal of biochemistry.
[33] Takao Shimizu,et al. Hydroxyeicosanoids Bind to and Activate the Low Affinity Leukotriene B4 Receptor, BLT2* , 2001, The Journal of Biological Chemistry.
[34] Takao Shimizu,et al. Co-expression of two LTB4 receptors in human mononuclear cells. , 2001, Life sciences.
[35] C. Serhan,et al. Cutting Edge: Nociceptin Stimulates Neutrophil Chemotaxis and Recruitment: Inhibition by Aspirin-Triggered-15-Epi-Lipoxin A41 , 2001, The Journal of Immunology.
[36] C. Hougaard,et al. Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes. , 2001, Biochimica et biophysica acta.
[37] K. Austen,et al. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Shimizu,et al. Leukotriene B4: metabolism and signal transduction. , 2001, Archives of biochemistry and biophysics.
[39] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[40] C. Austin,et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. , 2001, American journal of respiratory and critical care medicine.
[41] C. Serhan,et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. , 2001, The American journal of pathology.
[42] R. Stocco,et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. , 2001, Biochemical pharmacology.
[43] S. Doglia,et al. Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. , 2001, American journal of respiratory and critical care medicine.
[44] M. Maguire,et al. A Novel Hepatointestinal Leukotriene B4 Receptor , 2000, The Journal of Biological Chemistry.
[45] O. Civelli,et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. , 2000, Molecular pharmacology.
[46] J. Varga,et al. Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. , 2000, Biochemistry.
[47] J. Stankova,et al. IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils1 , 2000, The Journal of Immunology.
[48] C. Godson,et al. Lipoxins: novel anti-inflammatory therapeutics? , 2000, Current opinion in investigational drugs.
[49] Jilly F. Evans,et al. Characterization of the Human Cysteinyl Leukotriene 2 Receptor* , 2000, The Journal of Biological Chemistry.
[50] A. Fanning,et al. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. , 2000, The Journal of biological chemistry.
[51] T. Saito,et al. Molecular cloning and characterization of another leukotriene B4 receptor. , 2000, The Journal of biological chemistry.
[52] B. Levy,et al. Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.
[53] S. Dahlén,et al. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. , 2000, European journal of pharmacology.
[54] S. Dahlén,et al. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. , 2000, European journal of pharmacology.
[55] R. Snyderman,et al. Targeted Disruption of the Leukotriene B4Receptor in Mice Reveals Its Role in Inflammation and Platelet-Activating Factor–Induced Anaphylaxis , 2000, The Journal of experimental medicine.
[56] U. V. von Andrian,et al. Bltr Mediates Leukotriene B4–Induced Chemotaxis and Adhesion and Plays a Dominant Role in Eosinophil Accumulation in a Murine Model of Peritonitis , 2000, The Journal of experimental medicine.
[57] Takao Shimizu,et al. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. , 2000, The Journal of experimental medicine.
[58] Takao Shimizu,et al. Cell-Specific Transcriptional Regulation of Human Leukotriene B4 Receptor Gene , 2000, The Journal of experimental medicine.
[59] Y. Masuho,et al. The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 Receptor , 2000 .
[60] B. Olde,et al. Cloning and characterization of cDNA encoding a novel human leukotriene B(4) receptor. , 2000, Biochemical and biophysical research communications.
[61] P. Devillier,et al. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition. , 2000, Cardiovascular research.
[62] G. Rovati,et al. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. , 2000, Molecular pharmacology.
[63] C. Serhan,et al. Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation , 2000, The Journal of experimental medicine.
[64] J. Falgueyret,et al. LTA4-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB4 receptor of human polymorphonuclear leukocytes , 2000 .
[65] M. Richter,et al. Effects of eicosanoids, neuromediators and bioactive peptides on murine airways. , 2000, European journal of pharmacology.
[66] C. Serhan,et al. Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.
[67] Y. Masuho,et al. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. , 2000, Biochemical and biophysical research communications.
[68] J. Falgueyret,et al. LTA(4)-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB(4) receptor of human polymorphonuclear leukocytes. , 2000, Biochimica et biophysica acta.
[69] T. Ohishi,et al. Molecular cloning and characterization of another leukotriene B 4 receptor , 2000 .
[70] C. Clish,et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[71] Takao Shimizu,et al. Cloning and Characterization of Rat Leukotriene B4 Receptor , 1999 .
[72] J. Chambers,et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. , 1999, Molecular pharmacology.
[73] M. Freeman,et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. , 1999, The Journal of clinical investigation.
[74] T. Arinami,et al. Linkage and association of atopic asthma to markers on chromosome 13 in the Japanese population. , 1999, Human molecular genetics.
[75] M. Yeadon,et al. M1/MUC5AC mucin released by human airways in vitro. , 1999, The European respiratory journal.
[76] D. A. Walsh,et al. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats , 1999, British journal of pharmacology.
[77] Jilly F. Evans,et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.
[78] C. Serhan,et al. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.
[79] R. Lefkowitz,et al. Heptahelical Receptor Signaling: Beyond the G Protein Paradigm , 1999, The Journal of cell biology.
[80] L. Bjeldanes,et al. Lipoxin A4: a new class of ligand for the Ah receptor. , 1999, Biochemistry.
[81] B. Levy,et al. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin‐triggered lipoxin A4 , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[82] R. Doms,et al. Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells* , 1999, The Journal of Biological Chemistry.
[83] S. Dahlén,et al. Leukotriene C4 Is a Tight-binding Inhibitor of Microsomal Glutathione Transferase-1 , 1999, The Journal of Biological Chemistry.
[84] Y. Taketani,et al. Characterization of the leukotriene B4 receptor in porcine leukocytes. Separation and reconstitution with heterotrimeric GTP-binding proteins. , 1999, European journal of biochemistry.
[85] K. Masuda,et al. Cloning and characterization of rat leukotriene B(4) receptor. , 1999, Biochemical and biophysical research communications.
[86] H. Young,et al. Ca2+-dependent production and release of IL-8 in human neutrophils. , 1998, Journal of immunology.
[87] J. Stankova,et al. Signalling through the leukotriene B4 receptor involves both alphai and alpha16, but not alphaq or alpha11 G-protein subunits. , 1998, The Biochemical journal.
[88] A. Luster,et al. Molecular and Biological Characterization of the Murine Leukotriene B4 Receptor Expressed on Eosinophils , 1998, The Journal of experimental medicine.
[89] A. Sabirsh,et al. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[90] A. Sjölander,et al. Leukotriene D4 induces a rapid increase in cAMP in the human epithelial cell line, Int 407: a potential role for this signal in the regulation of calcium influx through the plasma membrane. , 1998, Cell calcium.
[91] M. Yacoub,et al. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. , 1998, Circulation.
[92] M. Smith,et al. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. , 1998, The Journal of pharmacology and experimental therapeutics.
[93] C. Serhan,et al. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. , 1998, The Journal of clinical investigation.
[94] C. Serhan,et al. Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release , 1998, The Journal of experimental medicine.
[95] C. Clish,et al. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[96] Takao Shimizu,et al. Leukotriene D4 Activates Mitogen-activated Protein Kinase through a Protein Kinase Cα-Raf-1-dependent Pathway in Human Monocytic Leukemia THP-1 Cells* , 1998, The Journal of Biological Chemistry.
[97] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[98] V. Capra,et al. Pharmacological characterization of the cysteinyl‐leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro , 1998, British journal of pharmacology.
[99] C. Labat,et al. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. , 1998, The Journal of pharmacology and experimental therapeutics.
[100] R. Panettieri,et al. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. , 1998, American journal of respiratory cell and molecular biology.
[101] The leukotriene B 4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD 4-positive cells , 1998 .
[102] B. Levy,et al. Polyisoprenyl phosphates in intracellular signalling , 1997, Nature.
[103] A. M. Lefer,et al. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[104] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[105] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[106] B. Undem,et al. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. , 1997, The Journal of pharmacology and experimental therapeutics.
[107] T. Takano,et al. Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor* , 1997, The Journal of Biological Chemistry.
[108] C. Serhan. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? , 1997, Prostaglandins.
[109] W. Wahli,et al. The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.
[110] D. Underwood,et al. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. , 1996, American journal of respiratory and critical care medicine.
[111] C. Brink,et al. Cysteinyl leukotriene receptors in the human lung: what's new? , 1996, Trends in pharmacological sciences.
[112] C. Serhan,et al. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. , 1996, Journal of immunology.
[113] M. H. Lee,et al. Aspirin-Triggered Lipoxins (15-epi-LX) Are Generated by the Human Lung Adenocarcinoma Cell Line (A549)–Neutrophil Interactions and Are Potent Inhibitors of Cell Proliferation , 1996, Molecular medicine.
[114] E. Barnard,et al. Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells* , 1996, The Journal of Biological Chemistry.
[115] L. Zheng,et al. Leukotriene D4-induced mobilization of intracellular Ca2+ in epithelial cells is critically dependent on activation of the small GTP-binding protein Rho. , 1996, The Biochemical journal.
[116] N. Uozumi,et al. cDNA Cloning, Expression, and Mutagenesis Study of Leukotriene B4 12-Hydroxydehydrogenase (*) , 1996, The Journal of Biological Chemistry.
[117] J. Rokach,et al. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels. , 1996, The Journal of pharmacology and experimental therapeutics.
[118] C. Serhan,et al. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.
[119] W. Wahli,et al. The PPARalpha-leukotriene B4 pathway to inflammation control. , 1996, Nature.
[120] C. Serhan,et al. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. , 1995, Biochemistry.
[121] D. Golan,et al. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. , 1995, Circulation.
[122] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[123] C. Labat,et al. Leukotriene receptors on human pulmonary vascular endothelium , 1995, British journal of pharmacology.
[124] D. Underwood,et al. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.
[125] H. Rennke,et al. Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. , 1995, Kidney international.
[126] A. Ford-hutchinson,et al. Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritis. , 1995, Journal of lipid mediators and cell signalling.
[127] H. Toh,et al. Molecular evolution of receptors for eicosanoids , 1995, FEBS letters.
[128] M. Engström,et al. The regulation of leukotriene D4-induced calcium influx in human epithelial cells involves protein tyrosine phosphorylation. , 1995, Cell calcium.
[129] J. Evans,et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. , 1995, Canadian journal of physiology and pharmacology.
[130] J. Drazen,et al. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.
[131] T. Abram,et al. Characterisation of leukotriene receptors on rat lung strip. , 1994, European journal of pharmacology.
[132] T. Abram,et al. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. , 1994, European journal of pharmacology.
[133] B. Levy,et al. Cell‐Cell Interactions in Lipoxin Generation and Characterization of Lipoxin A4 Receptors a , 1994, Annals of the New York Academy of Sciences.
[134] Toshio Kitazawa,et al. A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase , 1994, The Journal of general physiology.
[135] C. Serhan,et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.
[136] K. Metters,et al. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung. , 1994, The Journal of pharmacology and experimental therapeutics.
[137] M. Yacoub,et al. Preferential Vasoconstriction to Cysteinyl Leukotrienes in the Human Saphenous Vein Compared With the Internal Mammary Artery: Implications for Graft Performance , 1994, Circulation.
[138] M E Maragoudakis,et al. Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction. , 1994, European journal of pharmacology.
[139] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[140] B. Spur,et al. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet‐activating factor and N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine , 1994, Allergy.
[141] C. Andresen,et al. Leukotriene D4 receptor antagonism reduces airway hyperresponsiveness in monkeys. , 1994, Pulmonary pharmacology.
[142] C. Serhan,et al. Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. , 1994, Biochemistry.
[143] D. Woodward,et al. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro , 1994, Journal of leukocyte biology.
[144] C. Brink,et al. Leukotriene receptors and their selective antagonists. , 1994, Advances in prostaglandin, thromboxane, and leukotriene research.
[145] M. Accomazzo,et al. Correlation between leukotriene D4-induced contraction and cytosolic calcium elevation: a quantitative and simultaneous evaluation in smooth muscle. , 1994, The Journal of pharmacology and experimental therapeutics.
[146] J. Maclouf,et al. Formation of sulphidopeptide‐leukotrienes by cell‐cell interaction causes coronary vasoconstriction in isolated, cell‐perfused heart of rabbit , 1993, British journal of pharmacology.
[147] L. Smith,et al. Inhibition of leukotriene D4‐induced bronchoconstriction in subjects with asthma: a concentration‐effect study of ICI 204,219 , 1993, Clinical pharmacology and therapeutics.
[148] K. Matsushima,et al. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. , 1993, International immunology.
[149] B. Chapnick,et al. Antagonism of LTD4-evoked relaxation in canine renal artery and vein. , 1993, The American journal of physiology.
[150] Y. Taketani,et al. Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase. , 1993, The Journal of biological chemistry.
[151] J. Martin,et al. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. , 1993, The American review of respiratory disease.
[152] J. Grider,et al. Characterization of distinct receptors for the peptidyl leukotrienes LTC4 and LTD4/LTE4 coupled to the same signaling pathway in isolated gastric muscle cells. , 1993, The Journal of pharmacology and experimental therapeutics.
[153] B. Chapnick,et al. Leukotrienes C4 and D4 are potent endothelium-dependent relaxing agents in canine splanchnic venous capacitance vessels. , 1993, Circulation research.
[154] T. Abram,et al. Characterisation of the peptido-leukotriene receptor PL2 on the ferret spleen strip. , 1993, European journal of pharmacology.
[155] D. Weinreich,et al. Electrophysiological properties and chemosensitivity of guinea pig nodose ganglion neurons in vitro. , 1993, Journal of the autonomic nervous system.
[156] D. Weinreich,et al. Immunologically induced neuromodulation of guinea pig nodose ganglion neurons. , 1993, Journal of the autonomic nervous system.
[157] C. Serhan,et al. Induction of functional lipoxin A4 receptors in HL-60 cells. , 1993, Blood.
[158] T. Haahtela,et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.
[159] R. Zamboni,et al. Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung. , 1993, The Journal of biological chemistry.
[160] M. Yacoub,et al. Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotriene C4. , 1993, Cardioscience.
[161] J. Stankova,et al. Differential regulation of cytokine and cytokine receptor genes by PAF, LTB4 and PGE2. , 1993, Journal of lipid mediators.
[162] D. Nicholson,et al. Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung. , 1993, European journal of pharmacology.
[163] K. C. Kim,et al. Involvement of a signal transduction mechanism in ATP-induced mucin release from cultured airway goblet cells. , 1993, American journal of respiratory cell and molecular biology.
[164] K. Austen,et al. Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[165] C. Labat,et al. A second cysteinyl leukotriene receptor in human lung. , 1992, The Journal of pharmacology and experimental therapeutics.
[166] M. Yacoub,et al. Effects of leukotrienes C4 and D4 on human isolated saphenous veins. , 1992, British journal of clinical pharmacology.
[167] B. Beckman,et al. Actions of Lipoxins A4 and B4 on Signal Transduction Events in Friend Erythroleukemia Cells , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[168] G. Rovati,et al. Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma. , 1992, Biochemical pharmacology.
[169] J. McClary,et al. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. , 1992, Gene.
[170] C. Serhan,et al. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. , 1992, The Journal of biological chemistry.
[171] R. Eddy,et al. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. , 1992, Genomics.
[172] B. Spur,et al. The effects of lipoxin A4 on airway responses in asthmatic subjects. , 1992, The American review of respiratory disease.
[173] E. Prossnitz,et al. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. , 1992, Biochemical and biophysical research communications.
[174] U. Francke,et al. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. , 1992, The Journal of biological chemistry.
[175] T. Kobayashi,et al. In vivo pharmacologic profile of ONO-1078: a potent, selective and orally active peptide leukotriene (LT) antagonist. , 1992, Japanese journal of pharmacology.
[176] A. Guhlmann,et al. Transport and in vivo elimination of cysteinyl leukotrienes. , 1992, Advances in enzyme regulation.
[177] T. Kobayashi,et al. Effect of a peptide leukotriene antagonist, ONO-1078 on antigen-induced airway microvascular leakage in actively sensitized guinea pigs. , 1992, Life sciences.
[178] R. Snyderman,et al. Receptor class desensitization of leukocyte chemoattractant receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[179] P. Siegl,et al. Leukotriene D4 increases both the force of contraction and polyphosphoinositide formation in guinea-pig papillary muscle. , 1991, European journal of pharmacology.
[180] J. Lindgren,et al. Formation and proliferative effects of lipoxins in human bone marrow. , 1991, Biochemical and biophysical research communications.
[181] K. Maghni,et al. Leukotriene B4 receptors on guinea pig alveolar eosinophils. , 1991, The Journal of pharmacology and experimental therapeutics.
[182] J. Cheng,et al. Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.
[183] D. Aharony,et al. Evidence for leukotriene D4 receptors in guinea pig left atria. , 1991, The Journal of pharmacology and experimental therapeutics.
[184] Melvin I. Simon,et al. Diversity of G proteins in signal transduction , 1991, Science.
[185] B. Undem,et al. Role of peptidoleukotrienes in capsaicin‐sensitive sensory fibre‐mediated responses in guinea‐pig airways. , 1991, The Journal of physiology.
[186] R. Krell,et al. Peptide leukotrienes: current status of research. , 1991, Journal of medicinal chemistry.
[187] P. Piper,et al. Effect of ICI 198,615, SK+F 104,353, MK-571 and CGP45715A on cysteinyl leukotriene-induced responses in guinea-pig heart. , 1991, Prostaglandins.
[188] A. Ford-hutchinson,et al. Characterization of the leukotriene D4 receptor in hyperreactive rat lung. , 1991, European journal of pharmacology.
[189] C. Serhan,et al. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. , 1991, Biological mass spectrometry.
[190] S. Crooke,et al. Regulation of topoisomerase I and II activities by cyclic nucleotide- and phospholipid-dependent protein kinases. Effects of interactions between the two transduction pathways. , 1991, Receptor.
[191] C. Chan,et al. Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig. , 1991, International archives of allergy and applied immunology.
[192] S. Dahlén,et al. Lipoxins inhibit microvascular inflammatory actions of leukotriene B4. , 1991, Advances in experimental medicine and biology.
[193] T. Andersson,et al. Leukotriene D4 and E4 induce transmembrane signaling in human epithelial cells. Single cell analysis reveals diverse pathways at the G-protein level for the influx and the intracellular mobilization of Ca2+. , 1990, The Journal of biological chemistry.
[194] Y. Seyama,et al. Characterization of the guinea pig lung membrane leukotriene D4 receptor solubilized in an active form. Association and dissociation with an islet-activating protein-sensitive guanine nucleotide-binding protein. , 1990, The Journal of biological chemistry.
[195] T. Ishikawa,et al. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. , 1990, The Journal of biological chemistry.
[196] E. Wheeldon,et al. Leukotriene D4 (LTD4) induces mucus secretion from goblet cells in the guinea pig respiratory epithelium. , 1990, Experimental lung research.
[197] D. Aharony,et al. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents. , 1990, The Journal of pharmacology and experimental therapeutics.
[198] R. Kream,et al. Release of substance P from guinea pig trachea leukotriene D4. , 1990, Experimental lung research.
[199] T. Abram,et al. The inhibition of [3H]leukotriene D4 binding to guinea-pig lung membranes. The correlation of binding affinity with activity on the guinea-pig ileum. , 1990, European journal of pharmacology.
[200] T. Abram,et al. Evidence for two leukotriene receptor types in the guinea-pig isolated ileum. , 1990, European journal of pharmacology.
[201] J. Sabol,et al. MDL 28,753, an agonist of LTD4 but an antagonist of LTC4 in longitudinal muscle of guinea pig ileum. , 1990, The Journal of pharmacology and experimental therapeutics.
[202] F. Luscinskas,et al. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: Dissociation between lipid remodeling and adhesion , 1990, Journal of cellular physiology.
[203] R. Keith,et al. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist. , 1990, The American review of respiratory disease.
[204] B. Spur,et al. Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils. , 1990, Biochemical and biophysical research communications.
[205] D. Aharony,et al. Specific binding of 3H-ICI 198,615, a potent LTD4 antagonist, to guinea pig cardiac ventricular membranes. , 1990, Prostaglandins.
[206] T. Watanabe,et al. Solubilization and characterization of leukotriene B4 receptor-GTP binding protein complex from porcine spleen. , 1990, Biochemical and biophysical research communications.
[207] F. Luscinskas,et al. Ca2+ mobilization with leukotriene A4 and epoxytetraenes in human neutrophils. , 1990, Biochemical pharmacology.
[208] R. Krell,et al. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. , 1990, The Journal of pharmacology and experimental therapeutics.
[209] H. Sarau,et al. Signal transduction processes for the LTD4 receptor. , 1990, Advances in prostaglandin, thromboxane, and leukotriene research.
[210] H. Sarau,et al. Mechanisms of leukotriene E4 partial agonist activity at leukotriene D4 receptors in differentiated U-937 cells. , 1989, The Journal of biological chemistry.
[211] B. Spur,et al. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.
[212] J. Brody,et al. Mechanisms of airway goblet cell mucin release: studies with cultured tracheal surface epithelial cells. , 1989, American journal of respiratory cell and molecular biology.
[213] E. Corey,et al. Localization of the site of the bronchoconstrictor effects of leukotriene C4 compared with that of histamine in asthmatic subjects. , 1989, The American review of respiratory disease.
[214] K. Chung,et al. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig. , 1989, Clinical science.
[215] D. Underwood,et al. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes. , 1989, The Journal of pharmacology and experimental therapeutics.
[216] M. Slivjak,et al. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion. , 1989, Prostaglandins.
[217] K. Badr,et al. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[218] K. Jungermann,et al. Mechanism of action of cysteinyl leukotrienes on glucose and lactate balance and on flow in perfused rat liver. Comparison with the effects of sympathetic nerve stimulation and noradrenaline. , 1989, European journal of biochemistry.
[219] H. Sarau,et al. The signal transduction system of the leukotriene D4 receptor. , 1989, Trends in pharmacological sciences.
[220] D. Aharony,et al. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors. , 1989, The Journal of pharmacology and experimental therapeutics.
[221] P. Sterk,et al. The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo. , 1989, The American review of respiratory disease.
[222] R. Young. Structural analysis of sulfido-peptide leukotrienes: application to the design of potent and specific antagonists of leukotriene D4. , 1989, Advances in prostaglandin, thromboxane, and leukotriene research.
[223] J. Reid,et al. Effect of inhaled leukotriene C4 on cardiopulmonary function. , 1989, The American review of respiratory disease.
[224] W. Powell,et al. Metabolism of leukotriene B4 and related substances by polymorphonuclear leukocytes. , 1989, Advances in prostaglandin, thromboxane, and leukotriene research.
[225] A. Ford-hutchinson,et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.
[226] V. Lankin,et al. [Effects of lipoxin B on colony-forming capacity of human peripheral blood mononuclear cells in diffusion chambers]. , 1989, Biulleten' eksperimental'noi biologii i meditsiny.
[227] H. Sarau,et al. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells. , 1988, The Journal of pharmacology and experimental therapeutics.
[228] N. Chegini,et al. The presence of leukotriene C4-binding sites in bovine corpora lutea of pregnancy. , 1988, Biology of reproduction.
[229] H. Shimano,et al. Enhanced synthesis and secretion of apolipoprotein E from sciatic nerves of streptozotocin-induced diabetic rats after injury. , 1988, Biochemical and biophysical research communications.
[230] J. Drazen,et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.
[231] N. Chegini,et al. Quantitative light microscopic autoradiographic study on [3H]leukotriene C4 binding to nonpregnant bovine uterine tissue. , 1988, Endocrinology.
[232] R. Secrest,et al. Endothelial‐Dependent Relaxation Induced by Leukotrienes C4, D4, and E4 in Isolated Canine Arteries , 1988, Circulation research.
[233] R. Levi,et al. Vasomotor Effects of Leukotrienes C4 and D4 on Cavian Pulmonary Artery and Aorta Characterization and Mechanisms a , b , 1988, Annals of the New York Academy of Sciences.
[234] M. Triggiani,et al. Cardiovascular and Metabolic Effects of Peptide Leukotrienes in Man a , 1988, Annals of the New York Academy of Sciences.
[235] P. Barnes,et al. Autoradiographic localization of leukotriene C4 and D4 binding sites in guinea-pig lung. , 1988, Prostaglandins.
[236] R. Krell,et al. Biochemical and Pharmacological Characterization of the Binding of the Selective Peptide‐Leukotriene Antagonist, 3H‐ICI 198,615, to Leukotriene D4 Receptors in Guinea‐Pig Lung Membranes , 1988, Annals of the New York Academy of Sciences.
[237] T. Itoh,et al. Some effects of leukotriene D4 on the mechanical properties of the guinea‐pig basilar artery , 1988, British journal of pharmacology.
[238] K. Jungermann,et al. Leukotrienes increase glucose and lactate output and decrease flow in perfused rat liver. , 1988, Biochemical and biophysical research communications.
[239] R. Murphy,et al. Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4. , 1988, The Journal of biological chemistry.
[240] T. Abram,et al. The binding of [3H]leukotriene C4 to guinea-pig lung membranes. The lack of correlation of LTC4 functional activity with binding affinity. , 1987, European journal of pharmacology.
[241] C. Labat,et al. EFFECTS OF VARIOUS PHARMACOLOGICAL AGENTS ON ISOLATED HUMAN BRONCHIAL AND PULMONARY ARTERIAL AND VENOUS MUSCLE PREPARATIONS CONTRACTED BY LEUKOTRIENE D4 , 1987, Fundamental & clinical pharmacology.
[242] R. Hall,et al. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. , 1987, The Journal of pharmacology and experimental therapeutics.
[243] S. Gross,et al. Peptidoleukotrienes induce an endothelium-dependent relaxation of guinea pig main pulmonary artery and thoracic aorta. , 1987, Prostaglandins.
[244] T. Torphy,et al. Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions. , 1987, The Journal of pharmacology and experimental therapeutics.
[245] R. Keith,et al. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.
[246] E. Goetzl,et al. Stimulation by leukotriene D4 of increases in the cytosolic concentration of calcium in dimethylsulfoxide-differentiated HL-60 cells. , 1987, The Journal of clinical investigation.
[247] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.
[248] M. Civelli,et al. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi. , 1987, The Journal of pharmacology and experimental therapeutics.
[249] E. Goetzl,et al. Specificity and cellular distribution of human polymorphonuclear leucocyte receptors for leukotriene C4. , 1987, Immunology.
[250] J. Hogg,et al. Comparative effects of leukotrienes on porcine pulmonary circulation in vitro and in vivo. , 1987, Journal of applied physiology.
[251] M. Nakamura,et al. Leukotriene C4- and D4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram: angiographic analysis. , 1987, Circulation.
[252] P. Bernstein,et al. Pharmacologic profile of chemically stable analogs of peptide leukotrienes. , 1987, European journal of pharmacology.
[253] T. Jones,et al. Effects of l‐serine borate on antagonism of leukotriene C4‐induced contractions of guinea‐pig trachea , 1987, British journal of pharmacology.
[254] H. Shahinian,et al. Effects of leukotrienes B4, C4, and D4 on rat mesenteric microcirculation. , 1987, The Journal of surgical research.
[255] S. Schwalm,et al. Pharmacological comparison of L-serine borate and glutathione as inhibitors of metabolism of LTC4 to LTD4 by the isolated guinea pig trachea. , 1987, Prostaglandins.
[256] H. Sarau,et al. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog. , 1987, The Journal of pharmacology and experimental therapeutics.
[257] C. Bonne,et al. Specific binding of leukotriene C4 to endothelial cell membranes. , 1987, Prostaglandins, leukotrienes, and medicine.
[258] E. R. Mcfadden,et al. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. , 1987, The American review of respiratory disease.
[259] M. Heymann,et al. The Differential Effects of Leukotriene C4 and D4 on the Pulmonary and Systemic Circulations in Newborn Lambs , 1987, Pediatric Research.
[260] K. Austen,et al. Binding of leukotriene C4 by glutathione transferase: a reassessment of biochemical and functional criteria for leukotriene receptors. , 1987, Federation proceedings.
[261] Austen Kf,et al. Binding of leukotriene C4 by glutathione transferase: a reassessment of biochemical and functional criteria for leukotriene receptors. , 1987 .
[262] A. Malik,et al. Leukotrienes and the pulmonary microcirculation. , 1987, The American review of respiratory disease.
[263] A. Betz,et al. Leukotriene C4 receptors in isolated brain capillaries. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.
[264] R. Krell,et al. In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.
[265] V. Fiedler,et al. Effects of intracoronary leukotriene D4 infusion on the coronary circulation, hemodynamics, and prostanoid release in porcine experiments. , 1987, Cardiology.
[266] E. Corey,et al. The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction. , 1987, The American journal of pathology.
[267] H. Wu,et al. Leukotriene-induced hydrolysis of inositol lipids in guinea pig lung: mechanism of signal transduction for leukotriene-D4 receptors. , 1987, Molecular pharmacology.
[268] P. Cannon,et al. Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. , 1986, The Journal of biological chemistry.
[269] J. Cristol,et al. High-affinity binding site for leukotriene C4 in human erythrocytes. , 1986, Biochimica et biophysica acta.
[270] K. Austen,et al. Subcellular distribution of leukotriene C4 binding units in cultured bovine aortic endothelial cells. , 1986, Journal of immunology.
[271] P. O'Byrne,et al. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. , 1986, The New England journal of medicine.
[272] D. Heistad,et al. Effects of leukotriene C4 on the cerebral microvasculature. , 1986, The American journal of physiology.
[273] H. Bisgaard,et al. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans , 1986, Clinical allergy.
[274] S. Tucker,et al. Differential rank order of potency for antagonism of LTC4- and LTD4-induced contractions of guinea pig trachea. , 1986, Prostaglandins, leukotrienes, and medicine.
[275] R. Patterson,et al. Characterization of the airway response to inhaled leukotriene D4 in normal subjects. , 1986, The American review of respiratory disease.
[276] D. Coursin,et al. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4. , 1986, The Journal of pharmacology and experimental therapeutics.
[277] T. Hökfelt,et al. Leukotriene C4 binding sites in the rat central nervous system. , 1986, European journal of pharmacology.
[278] J. Drazen. Inhalation challenge with sulfidopeptide leukotrienes in human subjects. , 1986, Chest.
[279] R. Patterson,et al. Comparison of cutaneous and bronchial reactivity to leukotriene D4 in humans. , 1986, The Journal of laboratory and clinical medicine.
[280] A. Goffinet. [Leukotriene C4 binding sites in the mouse forebrain: autoradiographic demonstration]. , 1986, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[281] A. Malik,et al. Effects of exogeneous leukotrienes on the pulmonary circulation. , 1985, Progress in clinical and biological research.
[282] J. Frölich,et al. Vascular and renal effects of leukotriene C4 in conscious rats. , 1985, The American journal of physiology.
[283] S. Crooke,et al. The binding of leukotriene C4 and leukotriene D4 to membranes of a smooth muscle cell line (BC3H1) and evidence that leukotriene induced contraction in these cells is mediated by thromboxane, protein and RNA syntheses. , 1985, European journal of pharmacology.
[284] S. Shak,et al. Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450. , 1985, Journal of Clinical Investigation.
[285] C. E. Hock,et al. Effects of peptide leukotrienes on cardiac dynamics in rat, cat, and guinea pig hearts. , 1985, The American journal of physiology.
[286] G. Folco,et al. Identification of specific binding sites for leukotriene C4 in membranes from human lung. , 1985, Biochemical pharmacology.
[287] H. Wu,et al. Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea-pig lung. , 1985, The Journal of pharmacology and experimental therapeutics.
[288] V. Fiedler,et al. Leukotrienes on porcine hemodynamics and prostanoid release. , 1985, International journal of cardiology.
[289] R. Secrest,et al. Leukotriene D4 relaxes canine renal and superior mesenteric arteries. , 1985, Circulation research.
[290] M. Pfeffer,et al. Mechanism of the negative inotropic action of leukotrienes C4 and D4 on isolated rat heart. , 1985, Cardiovascular research.
[291] E. Goetzl,et al. Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. , 1985, Journal of immunology.
[292] J. Douglas,et al. Influences of gender and maturation on responses of guinea-pig airway tissues to LTD4. , 1985, European journal of pharmacology.
[293] S. Crooke,et al. Characterization of [3H]leukotriene D4 binding sites in guinea-pig ventricular myocardium. , 1985, The Journal of pharmacology and experimental therapeutics.
[294] T. Jones,et al. Comparative study of the pulmonary effects of intravenous leukotrienes and other bronchoconstrictors in anaesthetized guinea pigs. , 1985, Prostaglandins.
[295] H. Bisgaard,et al. Leukotriene- and histamine-induced increases in vascular permeability and interstitial transport in the skin. , 1985, The Journal of investigative dermatology.
[296] K. Austen,et al. Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[297] R. Patterson,et al. The effect of inhaled leukotriene D4 in humans. , 1985, The American review of respiratory disease.
[298] A. Ford-hutchinson,et al. Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin. , 1985, The Journal of investigative dermatology.
[299] S. Crooke,et al. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents. , 1985, Molecular pharmacology.
[300] R. Townley,et al. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations. , 1985, The Journal of pharmacology and experimental therapeutics.
[301] Gorman Rr,et al. Evidence for leukotriene B4 receptors in human neutrophils. , 1985 .
[302] P. Ruppel,et al. Evidence for leukotriene B4 receptors in human neutrophils. , 1985, Advances in prostaglandin, thromboxane, and leukotriene research.
[303] P. Piper,et al. The actions of leukotrienes C4 and D4 in the porcine renal vascular bed. , 1985, Prostaglandins.
[304] R. Krell,et al. Pharmacological evidence for a distinct leukotriene C4 receptor in guinea-pig trachea. , 1984, The Journal of pharmacology and experimental therapeutics.
[305] H. Wu,et al. Identification of leukotriene D4 specific binding sites in the membrane preparation isolated from guinea pig lung. , 1984, Prostaglandins.
[306] R. Green,et al. Cardiovascular Effects of Leukotrienes in Neonatal Piglets: Role in Hypoxic Pulmonary Vasoconstriction? , 1984, Circulation research.
[307] H. Wu,et al. Regulation of ligand binding to leukotriene D4 receptors: effects of cations and guanine nucleotides. , 1984, European journal of pharmacology.
[308] R. Krell,et al. Pharmacological and biochemical evidence for metabolism of peptide leukotrienes by guinea-pig airway smooth muscle in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.
[309] P. Kadowitz,et al. Analysis of Responses to Leukotriene D4 in the Pulmonary Vascular Bed , 1984, Circulation research.
[310] S. Pong,et al. Lung tissue receptors for sulfidopeptide leukotrienes. , 1984, The Journal of allergy and clinical immunology.
[311] M. Hamberg,et al. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[312] R. Townley,et al. Evidence for a similar receptor site for binding of [3H] leukotriene E4 and [3H] leukotriene D4 to the guinea-pig crude lung membrane. , 1984, Biochemical and biophysical research communications.
[313] S. Levinson. Peptidoleukotriene binding in guinea pig uterine membrane preparations. , 1984, Prostaglandins.
[314] E. Corey,et al. Specific binding of leukotriene C4 to ileal segments and subcellular fractions of ileal smooth muscle cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[315] N. Barnes,et al. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. , 1984, Thorax.
[316] T. Jones,et al. Study of mechanisms mediating contraction to leukotriene C4, D4 and other bronchoconstrictors on guinea pig trachea. , 1984, Prostaglandins.
[317] B. Chapnick. Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. , 1984, The American journal of physiology.
[318] J. Gleason,et al. Effects of the leukotrienes on the vasculature and blood pressure of different species. , 1984, The Journal of pharmacology and experimental therapeutics.
[319] V. Fiedler,et al. Leukotriene D4-induced vasoconstriction of coronary arteries in anaesthetized dogs. , 1984, European heart journal.
[320] S. Nicosia,et al. Binding sites for 3H-LTC4 in membranes from guinea pig ileal longitudinal muscle. , 1984, Prostaglandins.
[321] R. Schellenberg,et al. Differential activity of leukotrienes upon human pulmonary vein and artery. , 1984, Prostaglandins.
[322] G. Feuerstein,et al. Cardiovascular and sympathetic effects of leukotriene D4 in renovascular and spontaneously hypertensive rats. , 1984, Clinical and Experimental Hypertension Part A Theory and Practice.
[323] J. Gleason,et al. 2-nor-leukotriene analogs: antagonists of the airway and vascular smooth muscle effects of leukotriene C4, D4 and E4. , 1983, Biochemical and biophysical research communications.
[324] E. Corey,et al. The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. , 1983, The Journal of biological chemistry.
[325] H. Wu,et al. Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. , 1983, Biochemical and biophysical research communications.
[326] D. Éthier,et al. Pharmacological study of the effects of leukotrienes C4, D4, E4 & F4 on guinea pig trachealis: interaction with FPL-55712. , 1983, Prostaglandins.
[327] E. Corey,et al. Specific receptors for leukotriene C4 on a smooth muscle cell line. , 1983, The Journal of clinical investigation.
[328] S. Greenwald,et al. Effects of intra-coronary administration of leukotriene D4 in the anaesthetized dog. , 1983, Prostaglandins.
[329] M. Wasserman,et al. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis. , 1983, European journal of pharmacology.
[330] R. Egan,et al. Leukotriene C4 binding to rat lung membranes. , 1983, The Journal of biological chemistry.
[331] C. Page,et al. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo. , 1983, Prostaglandins, leukotrienes, and medicine.
[332] G. Kaley,et al. Leukotriene D4 reduces coronary blood flow in the anesthetized dog. , 1983, Prostaglandins.
[333] G. Feuerstein,et al. Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. , 1983, The American journal of cardiology.
[334] M. Pfeffer,et al. Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. , 1983, The American journal of physiology.
[335] E. R. Mcfadden,et al. Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.
[336] R. Krell,et al. Heterogeneity of leukotriene receptions in guinea-pig trachea , 1983 .
[337] K. Frank Austen,et al. Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .
[338] E. Corey,et al. Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. , 1983, Prostaglandins.
[339] R. Krell,et al. Heterogeneity of leukotriene receptors in guinea-pig trachea. , 1983, Prostaglandins.
[340] Piper Pj,et al. Cardiac actions of leukotrienes B4, C4, D4, and E4 in guinea pig and rat in vitro. , 1983 .
[341] L. Letts,et al. Cardiac actions of leukotrienes B4, C4, D4, and E4 in guinea pig and rat in vitro. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.
[342] E. Corey,et al. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. , 1983, The Journal of investigative dermatology.
[343] C. Gill,et al. The effect of synthetic leukotrienes on tracheal microvascular permeability. , 1983, Prostaglandins.
[344] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[345] J. Shelhamer,et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. , 2015, The American review of respiratory disease.
[346] G. Dusting,et al. Coronary vasoconstriction induced by leukotrienes in the anaesthetized dog. , 1982, European journal of pharmacology.
[347] G. Feuerstein,et al. Leukotriene D4: cardiovascular and sympathetic effects in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. , 1982, The Journal of pharmacology and experimental therapeutics.
[348] E. Goetzl,et al. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. , 1982, Journal of immunology.
[349] W. Zapol,et al. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. , 1982, Science.
[350] G. Weissmann,et al. Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. , 1982, Biochemical and biophysical research communications.
[351] J. Fleisch,et al. Evidence for multiple leukotriene D4 receptors in smooth muscle. , 1982, Life sciences.
[352] S. Tucker,et al. Contraction of guinea pig uterus by synthetic leukotrienes. , 1982, Prostaglandins.
[353] H. Bisgaard,et al. The effect of leucotriene C4 and D4 on cutaneous blood flow in humans , 1982 .
[354] W. Henderson,et al. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. , 1982, Journal of immunology.
[355] E. Daniel,et al. Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle. , 1982, Canadian journal of physiology and pharmacology.
[356] Robert A. Lewis,et al. Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.
[357] E. Corey,et al. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. , 1982, The Journal of pharmacology and experimental therapeutics.
[358] H. Fukui,et al. Effects of arachidonic acid and bradykinin on the coronary flow, release of PGI2 and cardiac functions in the perfused guinea-pig heart. , 1982, Japanese journal of pharmacology.
[359] S. Dahlén,et al. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey , 1982, Nature.
[360] R. Baserga. Protein and RNA Synthesis , 1982 .
[361] H. Bisgaard,et al. The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. , 1982, Prostaglandins.
[362] G. Feuerstein,et al. Cardiovascular effects of leukotriene D4 in SHR and WKY rats. , 1981, European journal of pharmacology.
[363] H. Okuda,et al. Contractile activities of leukotrienes C4 and D4 on vascular strips from rabbits. , 1981, Life sciences.
[364] J. Gleason,et al. Contraction of isolated airway smooth muscle by synthetic leukotrienes C4 and D4. , 1981, Prostaglandins.
[365] S. Dahlén,et al. Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytes , 1981 .
[366] J. G. Hamilton,et al. Inhibition of antigen-induced histamine release and thromboxane synthase by FPL 55712, a specific SRA-A antagonist? , 1981, Biochemical pharmacology.
[367] S. Dahlén,et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[368] P. Paré,et al. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro , 1981, Nature.
[369] Bengt Samuelsson,et al. Leukotrienes are potent constrictors of human bronchi , 1980, Nature.
[370] J. Shelhamer,et al. Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. , 1980, The Journal of clinical investigation.
[371] E. Goetzl,et al. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). , 1980, Journal of immunology.
[372] M. A. Bray,et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.
[373] E. Corey,et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[374] E. Corey,et al. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[375] H. Morris,et al. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung , 1980, Nature.
[376] B. A. Holland,et al. Immediate hypersensitivity reactions of the heart: reduction of tachycardia and arrhythmias by the SRS-A antagonist FPL 55712. , 1980, Immunopharmacology.
[377] R. Levi,et al. Cardiac anaphylaxis: SRS-A potentiates and extends the effects of released histamine. , 1980, European journal of pharmacology.
[378] Bengt Samuelsson,et al. Stereospecific total synthesis of a "slow reacting substance" of anaphylaxis, leukotriene C-1 , 1980 .
[379] M. A. Bray,et al. CALCIUM IONOPHORE A23187 INDUCES RELEASE OF CHEMOKINETIC AND AGGREGATING FACTORS FROM POLYMORPHO‐NUCLEAR LEUCOCYTES , 1980, British journal of pharmacology.
[380] P. Masson,et al. The synthesis of a leukotriene with SRS-like activity , 1980 .
[381] M. Huber,et al. Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity. , 1979, Prostaglandins.
[382] R. Murphy,et al. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[383] B. Samuelsson,et al. Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds. , 1979, The Journal of biological chemistry.
[384] B. Samuelsson,et al. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[385] B. Samuelsson,et al. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. , 1979, The Journal of biological chemistry.
[386] B. Jakschik,et al. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[387] M. K. Bach,et al. On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid. , 1977, Prostaglandins.
[388] M. Hamberg,et al. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. , 1976, The Journal of biological chemistry.
[389] J. Tainer,et al. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets , 1975, Nature.
[390] J B Farmer,et al. Selective inhibitor of slow reacting substance of anaphylaxis. , 1973, Nature: New biology.
[391] J. Shire. Growth Hormone and Premature Ageing , 1973, Nature.
[392] K. Austen,et al. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. , 1973, Journal of immunology.
[393] H. Collier,et al. Effects of Prostaglandins on Human Bronchial Muscle , 1968, Nature.
[394] W E BROCKLEHURST,et al. The release of histamine and formation of a slow‐reacting substance (SRS‐A) during anaphylactic shock , 1960, The Journal of physiology.
[395] S. Howard. An unusual type of hernia. , 1953, Lancet.
[396] J. Mongar,et al. Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen; histamine release and muscular contraction. , 1951, Lancet.
[397] E. R. Trethewie,et al. THE LIBERATION OF A SLOW‐REACTING SMOOTH MUSCLE‐STIMULATING SUBSTANCE IN ANAPHYLAXIS , 1940 .
[398] W. Feldberg,et al. Liberation of histamine and formation of lysocithin‐like substances by cobra venom , 1938, The Journal of physiology.
[399] W. Feldberg,et al. The formation of lysocithin and of a muscle‐stimulating substance by snake venoms , 1938, The Journal of physiology.